• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Celldex Therapeutics (CLDX)

Common Shares
Sell: $30.00|Buy: $34.60|Change: 0.54 (1.62%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

Address

53 Frontage Road
Suite 200
Hampton
NJ
USA
08827

Website

https://www.celldex.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Celldex Therapeutics Inc Fourth Quarter Earnings Results for 20262027-02-25T00:00:00
Celldex Therapeutics Inc Annual Report for 20262027-02-25T00:00:00
Celldex Therapeutics Inc Third Quarter Earnings Results for 20262026-11-10T00:00:00
Celldex Therapeutics Inc Second Quarter Earnings Results for 20262026-08-07T00:00:00
Celldex Therapeutics Inc Annual General Meeting for 20262026-06-05T09:00:00
Celldex Therapeutics Inc First Quarter Earnings Results for 20262026-05-08T00:00:00
H.C. Wainwright's 4th Annual Inflammatory Skin Disease Virtual Conference2026-04-14T15:30:00

Previous key dates

NameKey Date
H.C. Wainwright's 4th Annual Inflammatory Skin Disease Virtual Conference2026-04-14T15:30:00
Leerink Global Healthcare Conference2026-03-10T15:40:00
TD Cowen 46th Annual Health Care Conference2026-03-04T09:10:00
Celldex Therapeutics Inc Fourth Quarter Earnings Results for 20252026-02-25T00:00:00
Celldex Therapeutics Inc Annual Report for 20252026-02-25T00:00:00
Guggenheim Emerging Outlook: Biotech Summit 20262026-02-11T15:30:00
8th Annual Evercore Healthcare Conference2025-12-02T15:00:00
TD Cowen Immunology & Inflammation Summit2025-11-13T09:30:00
Guggenheim 2nd Annual Healthcare Innovation Conference2025-11-11T10:00:00
Celldex Therapeutics Inc Third Quarter Earnings Results for 20252025-11-10T00:00:00
Morgan Stanley 23rd Annual Global Healthcare Conference2025-09-09T15:20:00
Phase 2 Topline EoE Results Conference Call & Webcast2025-08-19T16:30:00
Celldex Therapeutics Inc Second Quarter Earnings Results for 20252025-08-07T00:00:00
Celldex EAACI 76 Week CSU Conference Call2025-06-12T18:00:00
Celldex Therapeutics Inc Annual General Meeting for 20252025-06-05T09:00:00
Celldex Therapeutics Inc First Quarter Earnings Results for 20252025-05-08T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.